Search Ontology:
ChEBI
alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
- Term ID
- CHEBI:148786
- Synonyms
-
- 2-acetamido-2-deoxy-alpha-D-galacto-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranose
- 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
- GalNAc(a1-3)Gal(b1-3)b-GlcNAc
- N-[(2R,3R,4R,5R,6R)-2-[(2R,3R,4S,5S,6R)-2-[(2R,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
- Definition
- An amino trisaccharide consisting of 2-acetamido-2-deoxy-α-D-galactopyranose, β-D-galactopyranose and 2-acetamido-2-deoxy-β-D-glucopyranose residu joined in sequence by (1→3) glycosidic bonds.
- References
-
- glygen:G29787UO
- glytoucan:G29787UO
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Phenotype where environments contain alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Phenotype modified by environments containing alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Phenotype affecting alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
Human Disease Model